IBDEI077 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9539,1,2,0)
 ;;=2^95937
 ;;^UTILITY(U,$J,358.3,9539,1,3,0)
 ;;=3^Neuromuscular Junction Test
 ;;^UTILITY(U,$J,358.3,9540,0)
 ;;=20206^^73^579^2^^^^1
 ;;^UTILITY(U,$J,358.3,9540,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9540,1,2,0)
 ;;=2^20206
 ;;^UTILITY(U,$J,358.3,9540,1,3,0)
 ;;=3^Needle Biopsy of Musccle
 ;;^UTILITY(U,$J,358.3,9541,0)
 ;;=64795^^73^579^3^^^^1
 ;;^UTILITY(U,$J,358.3,9541,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9541,1,2,0)
 ;;=2^64795
 ;;^UTILITY(U,$J,358.3,9541,1,3,0)
 ;;=3^Biopsy of Nerve
 ;;^UTILITY(U,$J,358.3,9542,0)
 ;;=20200^^73^579^1^^^^1
 ;;^UTILITY(U,$J,358.3,9542,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9542,1,2,0)
 ;;=2^20200
 ;;^UTILITY(U,$J,358.3,9542,1,3,0)
 ;;=3^Muscle Biopsy, Superficial
 ;;^UTILITY(U,$J,358.3,9543,0)
 ;;=95921^^73^580^1^^^^1
 ;;^UTILITY(U,$J,358.3,9543,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9543,1,2,0)
 ;;=2^95921
 ;;^UTILITY(U,$J,358.3,9543,1,3,0)
 ;;=3^Autonomic Nerv Function Test
 ;;^UTILITY(U,$J,358.3,9544,0)
 ;;=95922^^73^580^2^^^^1
 ;;^UTILITY(U,$J,358.3,9544,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9544,1,2,0)
 ;;=2^95922
 ;;^UTILITY(U,$J,358.3,9544,1,3,0)
 ;;=3^ANS; Vasomotor Adrenergic Innervation
 ;;^UTILITY(U,$J,358.3,9545,0)
 ;;=95923^^73^580^3^^^^1
 ;;^UTILITY(U,$J,358.3,9545,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9545,1,2,0)
 ;;=2^95923
 ;;^UTILITY(U,$J,358.3,9545,1,3,0)
 ;;=3^ANS; Sudomotor
 ;;^UTILITY(U,$J,358.3,9546,0)
 ;;=284.9^^74^581^6
 ;;^UTILITY(U,$J,358.3,9546,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9546,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,9546,1,8,0)
 ;;=8^Aplastic Anemia,unspec
 ;;^UTILITY(U,$J,358.3,9546,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,9547,0)
 ;;=282.9^^74^581^10
 ;;^UTILITY(U,$J,358.3,9547,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9547,1,1,0)
 ;;=1^282.9
 ;;^UTILITY(U,$J,358.3,9547,1,8,0)
 ;;=8^Hemolytic Anemia,Hered
 ;;^UTILITY(U,$J,358.3,9547,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,9548,0)
 ;;=283.9^^74^581^8
 ;;^UTILITY(U,$J,358.3,9548,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9548,1,1,0)
 ;;=1^283.9
 ;;^UTILITY(U,$J,358.3,9548,1,8,0)
 ;;=8^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,9548,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,9549,0)
 ;;=283.0^^74^581^9
 ;;^UTILITY(U,$J,358.3,9549,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9549,1,1,0)
 ;;=1^283.0
 ;;^UTILITY(U,$J,358.3,9549,1,8,0)
 ;;=8^Hemolytic Anemia,Autoimmun
 ;;^UTILITY(U,$J,358.3,9549,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,9550,0)
 ;;=283.19^^74^581^11
 ;;^UTILITY(U,$J,358.3,9550,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9550,1,1,0)
 ;;=1^283.19
 ;;^UTILITY(U,$J,358.3,9550,1,8,0)
 ;;=8^Hemolytic Anemia,Microangiopathic
 ;;^UTILITY(U,$J,358.3,9550,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,9551,0)
 ;;=280.9^^74^581^12
 ;;^UTILITY(U,$J,358.3,9551,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9551,1,1,0)
 ;;=1^280.9
 ;;^UTILITY(U,$J,358.3,9551,1,8,0)
 ;;=8^Iron Defic Anemia
 ;;^UTILITY(U,$J,358.3,9551,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,9552,0)
 ;;=281.0^^74^581^17
 ;;^UTILITY(U,$J,358.3,9552,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9552,1,1,0)
 ;;=1^281.0
 ;;^UTILITY(U,$J,358.3,9552,1,8,0)
 ;;=8^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,9552,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,9553,0)
 ;;=285.9^^74^581^19
 ;;^UTILITY(U,$J,358.3,9553,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9553,1,1,0)
 ;;=1^285.9
 ;;^UTILITY(U,$J,358.3,9553,1,8,0)
 ;;=8^Unspecified Anemia
 ;;^UTILITY(U,$J,358.3,9553,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,9554,0)
 ;;=281.8^^74^581^14
 ;;^UTILITY(U,$J,358.3,9554,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9554,1,1,0)
 ;;=1^281.8
 ;;^UTILITY(U,$J,358.3,9554,1,8,0)
 ;;=8^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,9554,2)
 ;;=^267979
 ;;^UTILITY(U,$J,358.3,9555,0)
 ;;=285.21^^74^581^2
 ;;^UTILITY(U,$J,358.3,9555,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9555,1,1,0)
 ;;=1^285.21
 ;;^UTILITY(U,$J,358.3,9555,1,8,0)
 ;;=8^Anemia End-Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,9555,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,9556,0)
 ;;=285.22^^74^581^3
 ;;^UTILITY(U,$J,358.3,9556,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9556,1,1,0)
 ;;=1^285.22
 ;;^UTILITY(U,$J,358.3,9556,1,8,0)
 ;;=8^Anemia In Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,9556,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,9557,0)
 ;;=285.29^^74^581^4
 ;;^UTILITY(U,$J,358.3,9557,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9557,1,1,0)
 ;;=1^285.29
 ;;^UTILITY(U,$J,358.3,9557,1,8,0)
 ;;=8^Anemia Oth Chronic Illness
 ;;^UTILITY(U,$J,358.3,9557,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,9558,0)
 ;;=285.1^^74^581^1
 ;;^UTILITY(U,$J,358.3,9558,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9558,1,1,0)
 ;;=1^285.1
 ;;^UTILITY(U,$J,358.3,9558,1,8,0)
 ;;=8^Ac Posthemorrhag Anemia
 ;;^UTILITY(U,$J,358.3,9558,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,9559,0)
 ;;=284.2^^74^581^13
 ;;^UTILITY(U,$J,358.3,9559,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9559,1,1,0)
 ;;=1^284.2
 ;;^UTILITY(U,$J,358.3,9559,1,8,0)
 ;;=8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,9559,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,9560,0)
 ;;=281.9^^74^581^7
 ;;^UTILITY(U,$J,358.3,9560,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9560,1,1,0)
 ;;=1^281.9
 ;;^UTILITY(U,$J,358.3,9560,1,8,0)
 ;;=8^Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,9560,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,9561,0)
 ;;=282.41^^74^581^18
 ;;^UTILITY(U,$J,358.3,9561,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9561,1,1,0)
 ;;=1^282.41
 ;;^UTILITY(U,$J,358.3,9561,1,8,0)
 ;;=8^Sickle Cell Thalassemia w/o crisis
 ;;^UTILITY(U,$J,358.3,9561,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,9562,0)
 ;;=284.11^^74^581^5
 ;;^UTILITY(U,$J,358.3,9562,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9562,1,1,0)
 ;;=1^284.11
 ;;^UTILITY(U,$J,358.3,9562,1,8,0)
 ;;=8^Antineoplastic Chemo Indcd Panycyt
 ;;^UTILITY(U,$J,358.3,9562,2)
 ;;=^340499
 ;;^UTILITY(U,$J,358.3,9563,0)
 ;;=284.12^^74^581^15
 ;;^UTILITY(U,$J,358.3,9563,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9563,1,1,0)
 ;;=1^284.12
 ;;^UTILITY(U,$J,358.3,9563,1,8,0)
 ;;=8^Oth Drug Indcd Pancytopenia
 ;;^UTILITY(U,$J,358.3,9563,2)
 ;;=^340500
 ;;^UTILITY(U,$J,358.3,9564,0)
 ;;=284.19^^74^581^16
 ;;^UTILITY(U,$J,358.3,9564,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9564,1,1,0)
 ;;=1^284.19
 ;;^UTILITY(U,$J,358.3,9564,1,8,0)
 ;;=8^Oth Pancytopenia
 ;;^UTILITY(U,$J,358.3,9564,2)
 ;;=^340501
 ;;^UTILITY(U,$J,358.3,9565,0)
 ;;=286.9^^74^582^3
 ;;^UTILITY(U,$J,358.3,9565,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9565,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,9565,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,9565,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,9566,0)
 ;;=446.6^^74^582^10
 ;;^UTILITY(U,$J,358.3,9566,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9566,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,9566,1,8,0)
 ;;=8^Thrombotic Thrombocytopenic Purpura (TTP)
 ;;^UTILITY(U,$J,358.3,9566,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,9567,0)
 ;;=451.9^^74^582^9
 ;;^UTILITY(U,$J,358.3,9567,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9567,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,9567,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,9567,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,9568,0)
 ;;=287.5^^74^582^7
 ;;^UTILITY(U,$J,358.3,9568,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9568,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,9568,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,9568,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,9569,0)
 ;;=287.1^^74^582^6
 ;;^UTILITY(U,$J,358.3,9569,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9569,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,9569,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,9569,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,9570,0)
 ;;=287.30^^74^582^5
 ;;^UTILITY(U,$J,358.3,9570,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9570,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,9570,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,9570,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,9571,0)
 ;;=238.71^^74^582^8
 ;;^UTILITY(U,$J,358.3,9571,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9571,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,9571,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,9571,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,9572,0)
 ;;=286.52^^74^582^1
 ;;^UTILITY(U,$J,358.3,9572,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9572,1,1,0)
 ;;=1^286.52
 ;;^UTILITY(U,$J,358.3,9572,1,8,0)
 ;;=8^Acquired Hemophilia
 ;;^UTILITY(U,$J,358.3,9572,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,9573,0)
 ;;=286.53^^74^582^2
 ;;^UTILITY(U,$J,358.3,9573,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9573,1,1,0)
 ;;=1^286.53
 ;;^UTILITY(U,$J,358.3,9573,1,8,0)
 ;;=8^Antiphospholipid w/ Hemor d/o
 ;;^UTILITY(U,$J,358.3,9573,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,9574,0)
 ;;=286.59^^74^582^4
 ;;^UTILITY(U,$J,358.3,9574,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9574,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,9574,1,8,0)
 ;;=8^Oth Hemor d/o d/t Anticoagulant
 ;;^UTILITY(U,$J,358.3,9574,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,9575,0)
 ;;=205.00^^74^583^1
 ;;^UTILITY(U,$J,358.3,9575,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9575,1,1,0)
 ;;=1^205.00
 ;;^UTILITY(U,$J,358.3,9575,1,8,0)
 ;;=8^A M L, W/O Remission
 ;;^UTILITY(U,$J,358.3,9575,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,9576,0)
 ;;=205.01^^74^583^2
 ;;^UTILITY(U,$J,358.3,9576,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9576,1,1,0)
 ;;=1^205.01
 ;;^UTILITY(U,$J,358.3,9576,1,8,0)
 ;;=8^A M L,In Remission
 ;;^UTILITY(U,$J,358.3,9576,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,9577,0)
 ;;=205.10^^74^583^4
 ;;^UTILITY(U,$J,358.3,9577,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,9577,1,1,0)
 ;;=1^205.10
 ;;^UTILITY(U,$J,358.3,9577,1,8,0)
 ;;=8^C M L,W/O Remission
 ;;^UTILITY(U,$J,358.3,9577,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,9578,0)
 ;;=205.11^^74^583^3
 ;;^UTILITY(U,$J,358.3,9578,1,0)
 ;;=^358.31IA^8^2
